NewcelX Ltd. (NCEL) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 16, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Apr 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NCEL SEC filings page.
This page shows NewcelX Ltd. (NCEL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
External financing and balance-sheet changes are carrying a business that still produces recurring operating cash deficits.
In FY2025, the company reported a net loss of-$8.3M but operating cash flow of-$2.8M , a wide gap that suggests noncash charges or working-capital effects softened the cash impact of reported losses. That gap was narrower in FY2024, when the operating loss was$2.1M against operating cash flow of-$1.1M , so earnings quality remains driven more by adjustments than by cash-generating operations.
The shift from negative equity of
Short-term liquidity weakened from a 2.8x current ratio in FY2022 to 0.1x in FY2024, then recovered only to 0.8x in FY2025, leaving current liabilities above current assets. The reported liquidity measure was 9.5 months of the latest annual operating outflow, describing a balance-to-outflow comparison rather than operating self-sufficiency.
Financial Health Signals
NewcelX Ltd. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
NewcelX Ltd. passes 2 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 3 profitability signals pass, 1 of 2 leverage/liquidity signals pass.
NewcelX Ltd. reported a net loss of $8.3M while operations used $2.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
NewcelX Ltd. held $2.2M in cash as of Q4 2025; long-term debt is not reported for that period.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
NCEL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
NCEL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q2'2510-Q | Q4'2420-F | Q2'2410-Q | Q4'2310-K | Q2'2310-Q | Q4'2210-K | Q2'2210-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.4M+1167.4% | $4.3M+263.5% | $903K-51.1% | $1.2M-47.4% | $1.8M-80.1% | $2.3M+10.3% | $9.3M+60.9% | $2.1M-75.1% |
| Current Assets | $3.2M+307.9% | $4.0M+238.4% | $780K-57.2% | $1.2M-46.9% | $1.8M-80.3% | $2.2M+11.0% | $9.2M+61.6% | $2.0M-75.5% |
| Cash & Equivalents | $2.2M+238.6% | $3.1M+455.8% | $650K-43.3% | $553K-66.5% | $1.1M-87.2% | $1.7M+22.0% | $8.9M+64.8% | $1.4M-80.9% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $1.7M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $4.2M-52.9% | $1.5M-86.1% | $8.9M+192.4% | $10.5M+59.6% | $3.0M-66.8% | $6.6M+7.5% | $9.2M+75.5% | $6.1M+51.7% |
| Current Liabilities | $4.2M-52.9% | N/A | $8.9M | $7.7M+98.3% | N/A | $3.9M+14.1% | $3.4M+39.8% | $3.4M+185.9% |
| Non-Current Liabilities | $0 | N/A | $0 | $2.7M+3.0% | N/A | $2.7M-0.9% | $5.8M+106.0% | $2.7M-4.9% |
| Total Equity | $7.3M+190.7% | $2.9M+131.1% | -$8.0M-568.0% | -$9.3M-116.2% | -$1.2M-1178.4% | -$4.3M-6.1% | $111K-79.5% | -$4.0M-195.1% |
| Retained Earnings | -$84.9M-10.8% | -$74.8M-3.3% | -$76.6M-8.8% | -$72.4M-10.0% | -$70.4M-20.9% | -$65.8M-30.7% | -$58.2M-39.6% | -$50.3M-46.5% |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Long-Term Debt.
NCEL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
NCEL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Note: The current ratio is below 1.0 (0.76), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Where NewcelX Ltd. Ranks
Frequently Asked Questions
Is NewcelX Ltd. profitable?
No, NewcelX Ltd. (NCEL) reported a net income of -$8.3M in fiscal year 2025.
What is NewcelX Ltd.'s EBITDA?
NewcelX Ltd. (NCEL) had EBITDA of -$2.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is NewcelX Ltd.'s return on equity (ROE)?
NewcelX Ltd. (NCEL) has a return on equity of -114.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is NewcelX Ltd.'s free cash flow?
NewcelX Ltd. (NCEL) recorded an outflow of $2.8M in free cash flow during fiscal year 2025. This represents a -158.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is NewcelX Ltd.'s operating cash flow?
NewcelX Ltd. (NCEL) recorded an outflow of $2.8M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are NewcelX Ltd.'s total assets?
NewcelX Ltd. (NCEL) had $11.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What are NewcelX Ltd.'s capital expenditures?
NewcelX Ltd. (NCEL) invested $8K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does NewcelX Ltd. spend on research and development?
NewcelX Ltd. (NCEL) invested $1.1M in research and development during fiscal year 2025.
What is NewcelX Ltd.'s current ratio?
NewcelX Ltd. (NCEL) had a current ratio of 0.76 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is NewcelX Ltd.'s debt-to-equity ratio?
NewcelX Ltd. (NCEL) had a debt-to-equity ratio of 0.58 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is NewcelX Ltd.'s return on assets (ROA)?
NewcelX Ltd. (NCEL) had a return on assets of -72.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is NewcelX Ltd.'s P/E ratio?
NewcelX Ltd. (NCEL) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $19.2M as of Sep 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is NewcelX Ltd.'s price-to-sales ratio?
NewcelX Ltd. (NCEL) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $19.2M as of Sep 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does NewcelX Ltd.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, NewcelX Ltd. (NCEL) held $2.2M in cash, cash equivalents and investments, and reported an operating cash outflow of $2.8M over that year. Dividing the one by the other, the reported balance equals about 10 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is NewcelX Ltd.'s Piotroski F-Score?
NewcelX Ltd. (NCEL) has a Piotroski F-Score of 2 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are NewcelX Ltd.'s earnings high quality?
NewcelX Ltd. (NCEL) reported a net loss of $8.3M while operations used $2.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.